During the First Half of 2025 “NABIDH” Platform Holds Over 10 Million Medical Records and Includes 1,888 Healthcare Facilities in Dubai
The number of medical records stored on the “NABIDH” platform – the unified medical records system overseen by the Dubai Health Authority – exceeded 10.41... Read more.
Dubai Health and GE HealthCare to enhance Point-of-Care Ultrasound (POCUS) education and practice in the MENA region
Dubai Health and GE HealthCare, a leading global medical technology and digital solutions innovator, have signed a Memorandum of Understanding (MoU) to collaborate... Read more.
WHO Recommends Injectable Lenacapavir for HIV Prevention
The World Health Organization (WHO) released new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis... Read more.
DoH-Abu Dhabi Launches Integrated Postnatal Care Programme to Enhance Support for Mothers and Newborns
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has launched the Integrated Postnatal Care Programme under the... Read more.
Novartis Receives Approval for First Malaria Medicine for Newborn Babies and Young Infants
Novartis announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new... Read more.
From Medical Spas to Skincare Innovation: Dr. Manon Pilon’s Expert Insights | AIDA 2025
Manon shared her journey, highlighting how the industry has transformed from primarily plastic surgery and early injectables to today’s advanced treatments... Read more.
GSK Completes Acquisition of Efimosfermin
GSK plc announced the completion of its previously announced acquisition of efimosfermin alfa from Boston Pharmaceuticals. Efimosfermin is a phase III-ready, potential... Read more.
IFRC Mourns the Killing of Five Iranian Red Crescent Colleagues
The International Federation of Red Cross and Red Crescent Societies (IFRC) has expressed deep sorrow over the deaths of five staff members and volunteers from the... Read more.
Phase 3 EMBARK Study Confirms XTANDI Plus Leuprolide Improves Overall Survival in Non-Metastatic Prostate Cancer
Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the overall survival (OS) analysis from the Phase 3 EMBARK study evaluating XTANDI® (enzalutamide),... Read more.
Two MSF facilities in Gaza reach all-time high acute malnutrition levels
Médecins Sans Frontières (MSF) has reported a sharp and unprecedented increase in acute malnutrition among people in Gaza, Palestine. According to the organization,... Read more.
